Meet our Board of Trustees

Under the leadership of our Chair, William Rucker, the Board of Trustees will have collective responsibility for the governance and development of the UK DRI. The Board will set its strategic direction and major policies, with the Directors and senior UK DRI staff, in line with the institute's objectives.

We're thrilled to have Trustees with such a diverse wealth of experience to lead our institute.

9

trustees form the UK DRI Board

William Rucker (Chair)

CEO, Lazard

"Helping create a world-class institute, dealing with one of the most serious diseases of our time, is critical. It is a real pleasure to join a team of such quality that has already been assembled and I am looking forward to working with them over the coming years. Dementia has touched many of our lives through relatives who have suffered and finding ways to make a positive impact could not be more important."

Rob Buckle

Chief Science Officer, Medical Research Council

"The UK DRI has been established to meet the challenge of dementia head-on, and I value the opportunity to help guide its development so that it can truly make a difference for those affected by dementia."

Fiona Carragher

Chief Policy and Research Officer, Alzheimer's Society

"The UK Dementia Research Institute brings new momentum to our understanding of disease, earlier diagnosis, treatment and care for those affected by dementia. I feel privileged to join the Board of Trustees and support this ambitious research endeavour"

Melanie Lee

CEO, LifeArc

"With longevity increasing, dementia is a crucial indication for us to understand, treat and prevent. To do these things we need breakthroughs in our understanding of neurological functions. Through this initiative UK DRI research should help millions of people."

Alasdair Moodie

Vice President, General Counsel, Europe, the Middle East and Africa at
Thermo Fisher Scientific

"As a life scientist turned lawyer, whose mother and maternal grandfather both died of Alzheimer’s disease, I joined the UK DRI Board of Trustees to make a difference."

Jo Pisani

Pharmaceutical and Life Science Consulting Leader, PwC

"As a business consultant to the lifesciences industry I have consulted on the need for new funding and collaboration models in order to tackle dementia. My parents both suffered from this terrible illness and I am keen to focus my efforts on improving our knowledge of disease and bringing effective therapies to patients"

Carol Routledge

Chief
Scientific Officer, Alzheimer’s Research UK

“I’m looking forward to helping guide the work of the UK DRI as it drives progress towards scientific breakthroughs that will lead to new ways to help people living with dementia.”

Dame Nancy Rothwell

President and Vice-Chancellor of The University of
Manchester

"The UK Dementia Research Institute offers a fantastic opportunity to tackle the serious and growing problem of dementia."

Anne Shevas

Former Head of News, HMRC

"I have seen the terrible effects of dementia on close family members and the effect the disease has on those caring for sufferers. I strongly believe that urgent and specific research into this increasingly common disease is essential. I would very much like to play a part in supporting and helping the UK Dementia Research Institute in any way I can."